Gemin X Pharmaceuticals

Develops and commercializes targeted cancer therapeutics to improve the lives of patients.

Launch date

1997

Employees

Market cap

Enterprise valuation

Malvern Iowa (HQ & founding location)

Date	Investors	Amount	Round
Jan 2001*	N/A	N/A	-
Jul 2007	N/A	N/A	Series A
Jul 2008	HBM Partners ProQuest Investments Merlin Biomed Caxton Advantage Life Sciences Fund SB Life Science VantagePoint Capital Partners Pinnacle Ventures HIG Capital Fonds de solidarité FTQ Sanderling Ventures	$38.0m	Series C
Jul 2009	N/A	$9.3m	Debt
Apr 2010	Caxton Advantage Life Sciences Fund Sanderling Ventures	$16.0m	Series D
Aug 2010	Caxton Advantage Life Sciences Fund Sanderling Ventures	$8.0m	Series E
Mar 2011	Cephalon	$225m	Acquisition
Total Funding		CAD84.5m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Gemin X Pharmaceuticals